Status:
COMPLETED
Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF
Lead Sponsor:
Acusphere
Conditions:
Congestive Heart Failure
Chronic Obstructive Pulmonary Disease
Phase:
PHASE1
Brief Summary
This study was conducted to evaluate the safety and pharmacokinetics of an echocardiographic contrast agent, AI-700, in patients with moderate to severe chronic obstructive pulmonary disease (COPD) an...
Detailed Description
In ongoing clinical trials, AI-700 is currently being evaluated for its value to provide enhanced echocardiography to detect CAD. The patient population is comprised of those patients who have chest p...
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00156780
Start Date
August 1 2004
End Date
July 1 2005
Last Update
October 23 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acusphere, Inc.
Watertown, Massachusetts, United States, 02472